Mural Oncology plc
MURA
$2.08
-$0.01-0.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.09% | 31.87% | 38.05% | 21.74% | 11.52% |
| Total Depreciation and Amortization | 19.80% | 21.99% | 36.81% | 32.88% | 53.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.24% | -96.94% | -89.62% | 38.23% | 53.02% |
| Change in Net Operating Assets | 178.98% | 85.48% | 55.14% | 23.80% | -279.18% |
| Cash from Operations | 18.69% | 27.21% | 33.82% | 26.35% | 9.27% |
| Capital Expenditure | 97.83% | 98.49% | 97.33% | 48.41% | 39.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 204.57% | 202.16% | -- | -- | -- |
| Cash from Investing | 202.51% | 199.69% | -633.78% | -2,495.04% | -2,007.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 64.22% | 103.49% |
| Cash from Financing | -99.94% | -99.95% | -99.96% | 64.32% | 103.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -136.01% | -100.53% | -156.69% | -- | -- |